About the Event

The MPS (Microphysiological Systems) World Summit will bring together a global audience, including institutions (government, health foundations, charities), the academic research community (universities, research institutes), environmental and human toxicity researchers, the pharmaceutical and other industries (cosmetics, chemical, and food industries), medical centers and practitioners, patient associations, and policymakers and testing centers—in a series of global conferences to create a roadmap for MPS technologies.

Full program at https://mpsworldsummit.com/virtual-june242021

Schedule

9am – 9:05
Welcome
Thomas Hartung, CAAT, Johns Hopkins University, United States 

9:05 – 9.35
Keynote Address: Advancing Alternative Methods at FDA
Suzanne Fitzpatrick, Food and Drug Administration (FDA), United States 

9:35 – 10:55
Short talks: Standardization, scaling-up, and quality control of platforms and cell sources

• Multi-organ microphysiological system coupled with mechanistic mathematical modelling for studying cardio-metabolic disorders
  Peter Gennemark, AstraZeneca, Sweden

• A robotized 1546 compound screen in a perfused 3D microfluidic angiogenesis assays
  Camilla Soragni, MIMETAS, the Netherlands

• PSIS workshop: the many roles of standards for organ-on-chip
  Monica Piergiovanni, European Commission, Joint Research Center (JRC), Belgium, Italy

• Supporting the adoption of microphysiological systems for COVID research
  Anthony Holmes, National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), United Kingdom 

10:55 – 11:00
Break 

11:00 – 12:00
Short talks: Obstacles to accomplishing regulatory acceptance 

• MPS initiatives for industrial implementation and regulatory acceptance in Japan
  Seiichi Ishida, National Institute of Health Sciences, Sojo University, Japan 

• A roadmap to overcoming obstacles to MPS regulatory acceptance: perspectives from technology providers
  Megan LaFollette, North American 3Rs Collaborative, United States 

• Applicability of organ-on-chip systems in toxicology and pharmacology
  Rob Vanderbriel, National Institute for Public Health and the Environment (RIVM), The Netherlands

12pm – 12:45
Panel Discussion: Perspectives on Regulatory Acceptance 

Moderator – Danilo Tagle, National Center for Advancing Translational Sciences (NCATS), United States 

• Anne Gourmelon, Organization for Economic Co-operation and Development (OECD) Test Guidelines Programme, France 

• Sonja Beken, European Medicines Agency (EMA), Belgium 

• Seiichi Ishida, National Institute of Health Sciences (NIHS), Japan 

• Jean Lou Dorne, European Food Safety Authority (EFSA), Italy 

• Donna Mendrick, Food and Drug Administration (FDA), United States 

• Elizabeth Mendez, Environmental Protection Agency (EPA), United States 

12:45 – 1:00
Q&A Session with Panelists, Poster Voting, and Young Scientist Award Announcement